Liver injury in COVID-19 - The culprit may not be COVID-19!

Affiliations

¹ Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
³ Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: virendrasingh100@hotmail.com.

Comment

Aditya Singh et al. J Hepatol. 2021 Sep.

. 2021 Sep;75(3):739-740.

doi: 10.1016/j.jhep.2021.03.010. Epub 2021 Mar 19.

¹ Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
³ Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: virendrasingh100@hotmail.com.

No abstract available

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest. Please refer to the accompanying ICMJE disclosure forms for further details.

Association of liver abnormalities with in-hospital mortality in patients with COVID-19.
Ding ZY, Li GX, Chen L, Shu C, Song J, Wang W, Wang YW, Chen Q, Jin GN, Liu TT, Liang JN, Zhu P, Zhu W, Li Y, Zhang BH, Feng H, Zhang WG, Yin ZY, Yu WK, Yang Y, Zhang HQ, Tang ZP, Wang H, Hu JB, Liu JH, Yin P, Chen XP, Zhang B; Tongji Multidisciplinary Team for Treating COVID-19 (TTTC). Ding ZY, et al. J Hepatol. 2021 Jun;74(6):1295-1302. doi: 10.1016/j.jhep.2020.12.012. Epub 2020 Dec 19. J Hepatol. 2021. PMID: 33347952 Free PMC article.

1. Ding Zy, Li Gx, Chen L., Shu C., Song J., Wang W., et al. Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol. 2021;74(6):1295–1302. - PMC - PubMed
1. Guan W-j, Ni Z-y, Hu Y., Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med. 2020;382(18):1708–1720. - PMC - PubMed
1. Kulkarni A.V., Kumar P., Tevethia H.V., Premkumar M., Arab J.P., Candia R., et al. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020 Aug;52(4):584–599. doi: 10.1111/apt.15916. - DOI - PMC - PubMed
1. Lavarone M., D'Ambrosio R., Soria A., Triolo M., Pugliese N., Del Poggio P., et al. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol. 2020;73(5):1063–1071. - PMC - PubMed
1. Moon A.M., Webb G.J., Aloman C., Armstrong M.J., Cargill T., Dhanasekaran R., et al. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. J Hepatol. 2020;73(3):705–708. - PMC - PubMed